Heparanase and tumor invasion patterns in human oral squamous cell carcinoma xenografts

被引:26
作者
Kurokawa, H
Katsube, K
Podyma, KA
Ikuta, M
Iseki, H
Nakajima, M
Akashi, T
Omura, K
Takagi, M
Yanagishita, M
机构
[1] Tokyo Med & Dent Univ, Grad Sch, Dept Hard Tissue Engn, Div Biochem,Bunkyo Ku, Tokyo 1138549, Japan
[2] Tokyo Med & Dent Univ, Grad Sch, Dept Adv Surg Therapeut, Div Biomatrix & Surg Pathol,Bunkyo Ku, Tokyo 1138549, Japan
[3] Tokyo Med & Dent Univ, Grad Sch, Div Adv Therapeut Sci, Bunkyo Ku, Tokyo 1138549, Japan
[4] Novartis Pharma KK, Tsukuba Res Inst, Discovery Res, Tsukuba, Ibaraki 3002611, Japan
[5] Tokyo Med & Dent Univ, Grad Sch, Dept Oral Restitution, Div Oral Hlth Sci, Tokyo 1138549, Japan
关键词
D O I
10.1111/j.1349-7006.2003.tb01433.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The role of heparanase, an endo-beta-glucuronidase specifically degrading heparan sulfate (HS) glycosaminoglycans, in the mechanism of cancer cell invasion was investigated. Three human oral squamous cell carcinoma (SCC) cell lines (i.e., HSC-2, HSC-3 and LMF4), exhibiting various degrees of invasiveness to their Surrounding tissues, were xenografted to the tongue of SCID mice in order to establish experimental cancer foci. Cancer cells and their surrounding tissues were examined for the expression of heparanase mRNA by an in situ hybridization technique, and for various basement membrane (BM)-associated molecules (i.e., perlecan, laminins and type IV collagen) by immunohistochemical procedures. BM structures surrounding cancer tissues were also examined by electron microscopy. Increasing levels of heparanase mRNA expression were observed with the progression of cancer invasiveness, as manifested by the destruction of BM structures. Enhanced heparanase enzyme activities in cancer tissues with more invasive properties were demonstrated by the disappearance of HIS glycosaminoglycans in the face of retained HS proteoglycan core proteins. These results demonstrated a positive correlation between the heparanase enzyme activities and the invasiveness of human oral SCC. The roles of heparanase in cancer cell invasion were not precisely clarified by the present morphological study, but the enhanced heparanase activity in an early phase of BM destruction by cancer cells suggested the participation of this enzyme from the early phase of cancer invasion. (Cancer Sci 2003; 94: 277-285).
引用
收藏
页码:277 / 285
页数:9
相关论文
共 53 条
[1]  
Akashi T, 1999, J PATHOL, V187, P223, DOI 10.1002/(SICI)1096-9896(199901)187:2<223::AID-PATH219>3.0.CO
[2]  
2-B
[3]   The extracellular matrix in epithelial biology: Shared molecules and common themes in distant phyla [J].
Ashkenas, J ;
Muschler, J ;
Bissell, MJ .
DEVELOPMENTAL BIOLOGY, 1996, 180 (02) :433-444
[4]   CLONING AND SEQUENCE-ANALYSIS OF DESMOSOMAL GLYCOPROTEIN-2 AND GLYCOPROTEIN-3 (DESMOCOLLINS) - CADHERIN-LIKE DESMOSOMAL ADHESION MOLECULES WITH HETEROGENEOUS CYTOPLASMIC DOMAINS [J].
COLLINS, JE ;
LEGAN, PK ;
KENNY, TP ;
MACGARVIE, J ;
HOLTON, JL ;
GARROD, DR .
JOURNAL OF CELL BIOLOGY, 1991, 113 (02) :381-391
[5]   Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis [J].
Curran, S ;
Murray, GI .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (13) :1621-1630
[6]   DEVELOPMENTAL-CHANGES IN HEPARAN-SULFATE EXPRESSION - INSITU DETECTION WITH MABS [J].
DAVID, G ;
BAI, XM ;
VANDERSCHUEREN, B ;
CASSIMAN, JJ ;
VANDENBERGHE, H .
JOURNAL OF CELL BIOLOGY, 1992, 119 (04) :961-975
[7]   STRUCTURAL DIFFERENCES OF HEPARAN SULFATES ACCORDING TO THE TISSUE AND SPECIES OF ORIGIN [J].
DIETRICH, CP ;
NADER, HB ;
STRAUS, AH .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1983, 111 (03) :865-871
[8]   THE ROLE OF PROTEOLYTIC-ENZYMES IN CANCER INVASION AND METASTASIS [J].
DUFFY, MJ .
CLINICAL & EXPERIMENTAL METASTASIS, 1992, 10 (03) :145-155
[9]   MAPPING OF DOMAINS IN HUMAN LAMININ USING MONOCLONAL-ANTIBODIES - LOCALIZATION OF THE NEURITE-PROMOTING SITE [J].
ENGVALL, E ;
DAVIS, GE ;
DICKERSON, K ;
RUOSLAHTI, E ;
VARON, S ;
MANTHORPE, M .
JOURNAL OF CELL BIOLOGY, 1986, 103 (06) :2457-2465
[10]  
FIDLER IJ, 1990, CANCER RES, V50, P6130